Scientific programme
Official XXIst International Pigment Cell Conference website - 21-24 Sept 2011, Bordeaux - France | updated: September 17 2011
-
Tuesday 20th, September 2011
to Rooms
D, E, FSpecial Interest Groups Meetings
Room D Eumelanet Workshop: Standardization of melanin chemistry
Chair: M. d'Ischia - S. Ito - K. Wakamatsu
Room E Vitiligo Global Issues Consensus Conference
Chairs: Y. Gauthier - A. Taïeb - M. Picardo
Room F IFPCS Development Group
Chairs: W. Pavan - R. Kelsh - H. Yamamoto - L. Kos
to Rooms
D, E, G, HRegional Council meetings
ASPCR - room D, ESPCR - room G, JSPCR - room H, PASPCR - room E
to Room F 1er iFPCS Council meeting
to CEB Registration opens
at Palais des Congrèsposter can be mounted for the whole meeting
poster prizes on Friday at Gala Dinnerto iFPCS Dinner
-
Wednesday 21st, September 2011
-
Thursday 22nd, September 2011
to Hall A PASPCR Aaron Lerner Lecture
Chairs: A. Slominski - R. Boissy - J. Pawelek
Hall A SL5: Aaron Lerner Special Lecture
C. Goding
Signalling and transcription in melanoma stem-like cellsto Hall A Plenary session III
Hall A Stem Cells: facts, fancy, fiction?
Chairs: C. Goding - L. Sommer - R. Halaban TBC
08:30 Hall A GL2
R.M. Hoffman :
Hair follicle pluripotent stem (hfPS) cells for regenerative medicine:
an advantageous alternative to ES and iPS cells09:00 to 09:20 Hall A IL16
E.K. Nishimura:
"Stem cell regulation by stem cells"09:20 to 09:40 Hall A IL17
L. Sommer:
"Neural crest stem cells and melanoma formation: a likely connection"09:40 to 09:52 Hall A C36
H. Aoki:
"Protective effect of Kit signaling for melanocyte stem cells against radiation-induced genotoxic stress"09:52 to 10:04 Hall A C37
S. Tabone-Eglinger:
"Dual function of membrane-bound KitL and potential role to anchor melanocyte stem cells in their niche"10:04 to 10:16 Hall A C38
E. V. Sviderskaya:
"Characterisation of pluripotent immortal postnatal mouse neural crest-like stem cells"10:16 to 10:28 Hall A C39
G. Walker:
"In vivo responses of melanocyte stem cells and other immature melanocytic cells to ultraviolet radiation-induced damage"to Coffee Break to Hall A Plenary session IV
Hall A Photoprotection and beyond: from melanosomes to melanins
Chairs: M. d'Ischia - K. Wakamatsu - T. Passeron
11:00 Hall A GL3
V. Sundstrom :
Femtobiology of Photoprotection11:30 Hall A GL4
E. Sprecher :
Keratin disorders associated with abnormal pigmentation: clinical and molecular insights12:00 to 12:12 Hall B C40
J.D. Simon:
"Ultraviolet Absorption Properties of Melanosomes Measured by Photoemission Electron Microscopy"12:12 to 12:24 Hall B C41
A. Napolitano:
"Pheomelanin is a prooxidant promoting DOPA conversion to a eumelanin coating: discovery of a non-enzymatic mimic of the natural casing process of melanosome assembly"12:24 to 12:36 Hall B C42
G. Barsh:
"Genomics of pattern: from Akitas to Zebras"12:36 to 12:48 Hall B C43
B.C. Bastian:
"Germline mutations in BAP1 predispose to melanocytic tumors"to Room E 2nd IFPCS Council Meeting
to Lunch break and Poster viewing to Halls A, B, C Concurrent sessions 10-12
Hall B CS10: Genetics of pigmentation and melanoma clinically-oriented
Chairs: R. Spritz - N. Soufir - D. Lacombe
14:30 to 14:50 Hall B IL18
N. Soufir:
"Pigmentation genes and melanoma: where are we now?"14:50 to 15:10 Hall B IL19
L. Larue:
"Murine models: coat color and melanoma"15:10 to 15:22 Hall B C44
A. Mogha:
"Uncovered role of Tyrosinase-related Protein 1 (TYRP1) in melanoma cells aggressiveness"15:22 to 15:34 Hall B C45
F. Morice-Picard:
"Molecular analysis of 246 patients with oculocutaneous albinism – the Bordeaux experience"15:34 to 15:46 Hall B C46
M. Sakaguchi:
"Ser727 phosphorylation in STAT3 plays a crucial role in nuclear translocation of STAT3 and growth in human melanoma cells and melanocytes"15:46 to 15:58 Hall B C47
J. Pawelek:
"First evidence for tumor cell-leukocyte fusion in human cancer: a melanoma brain metastasis with a donor-patient hybrid genome following allogeneic BMT"Hall A CS11: Vitiligo: basic science & medical clinically-oriented
Chairs: S.K. Hann - T. Anbar - P. Manga
14:30 to 14:50 Hall A IL20
S. Moretti:
"Vitiligo: an up-to-date"14:50 to 15:10 Hall A IL21
V.R. Attili:
"Acrofacial and genital depigmentation is a new pattern disease with features of both vitiligo and vitiligoid lichen sclerosus - A clinical and histopathological review of 58 cases"15:10 to 15:22 Hall A C48
S.K. Attili:
"Histopathological staging of vitiligo lesions- Implications for treatment"15:22 to 15:34 Hall A C49
J. Mosenson:
"A hot finding: mutant HSP70i to treat vitiligo"15:34 to 15:46 Hall A C50
R. Kumar:
"LXR-α as molecular switch that initiate transition from vitiligo lesional skin to repigmented skin ?"15:46 to 15:58 Hall A C51
Y. Zhou:
"“Bad soil”-- defective local microenvironment for melanocytes in vitiligo"Hall C CS12: Stress responses
Chairs: LF. Xiang - M.L. Dell'Anna - A. Mauviel
14:30 to 14:50 Hall C IL22
M. Picardo:
"Stress responses: "14:50 to 15:10 Hall C IL23
M.-D. Galibert:
"How does solar UV radiation initiate specific cellular responses?"15:10 to 15:22 Hall C C52
L. Marrot:
"Antioxydant defenses in human epidermal melanocytes and keratinocytes suggests that Nrf2 plays a peculiar role in epidermis: implication in vitiligo lesions "15:22 to 15:34 Hall C C53
E. Flori:
"The parrodiene derivative, 2,4,6-octatrienoic acid, acts as a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes in situ and in vitro via PPARγ activation"15:34 to 15:46 Hall C C54
J. Menter:
"Pigment Melanin Mediates a Redox Reaction between Adsorbed Nitric Oxide and O2 in vitro"15:46 to 15:58 Hall C C55
H.Y. Handoko:
"The immune response influences melanocyte proliferation after ultraviolet radiation exposure"to Coffee Break to Halls A, B, C Concurrent sessions 13-15
Hall A CS13: Neuroendocrinology of pigmentation
Chairs: A. Slominski - D.J. Tobin - M. Böhm
16:30 to 16:50 Hall A IL24
A. Slominski:
"Introduction to the neuroendocrinology of the pigmentary system"16:50 to 17:10 Hall A IL25
M. Bohm:
"Modulatory effects of a small peptide derivative of alpha-MSH, KdPT, on melanocyte responses to oxidative stress"17:10 to 17:22 Hall A C56
C. Skobowiat:
"Ultraviolet radiation A and B regulate the neuroendocrine stress response system in melanocyte/keratinocyte co-cultures"17:22 to 17:34 Hall A C57
J.C. Garcia-Borron:
"Regulation of human melanocortin 1 receptor (MC1R) signalling by β-arrestins"17:34 to 17:46 Hall A C58
A. Kokot:
"Tropisetron, a serotonin antagonist, modulates the inflammatory cell response of human epidermal melanocytes and keratinocytes after exposure of UVB light or TNF-alpha"Hall B CS14: Vitiligo: surgical-instrumental clinically-oriented
Chairs: N. Rabobee - S.V. Mulekar - C.C. Lan
16:30 to 16:50 Hall B IL26
C.-C. E. Lan:
"Monochromatic light for treatment of vitiligo"16:50 to 17:10 Hall B IL27
S.V. Mulekar:
"Experience of surgical procedures in childhood vitiligo"17:10 to 17:22 Hall B C60
P. Araujo:
"surgical management of vitiligo"17:22 to 17:34 Hall B C61
D. Ghia:
"To trypsinise, or not to trypsinise, that is the question "17:34 to 17:46 Hall B C62
S. Awasthi:
"Comparing the effect on the outcome of cold trypsinisation v/s warm trypsinisation in transplantation of autologous non cultured epidermal cell suspension in stable vitiligo - a prospective randomized study"17:46 to 17:58 Hall B C63
G. Garg:
"A comparative study of efficacy and safety of Modified Dermabrasion followed by NB-UVB therapy with Suction Blister Epidermal Grafting followed by NB-UVB therapy in stable vitiligo patients"Hall C CS15: Non Mouse animal models
Chairs: G . Erf - R. Kelsh - M.D. Galibert
16:30 to 16:50 Hall C IL28
R. N. Kelsh:
"Pigmentation in non-mouse models - fishing for insight, not just horsing around ?"16:50 to 17:10 Hall C IL29
G. Erf:
"Chicken models for vitiligo and other spontaneous autoimmune/autoinflammatory disorders"17:10 to 17:22 Hall C C64
E.E. Patton:
"Mitf mutations promote differentiated cell division and melanoma in zebrafish"17:22 to 17:34 Hall C C65
C. Andre:
"Canine melanoma: promising spontaneous models for genetics and therapies of human melanoma"17:34 to 17:46 Hall C C66
D.J. Tobin:
"Do epidermal melanocytes contribute to the erythema response in human skin post-UVB irradiation?"17:46 to 17:58 Hall C C67
T. Biedermann:
"Engineering melanoma progression in a humanized environment in vivo"to Halls
A, B, C, HRegional Societies Assemblies
ASPCR (Hall A), ESPCR (Hall B), JSPCR (Hall C), PASPCR (Hall H)
to Speaker's Dinner (Pierre Fabre) -
Friday 23rd, September 2011
Committee: B. Bastian - D. Fisher - C. Garbe - G. Ghanem - N. Hayward, L. Larue
→ The Society for Melanoma Research website
to Hall A Plenary sessions V - VI
08:30 to 10:30 Hall A Fundamental aspects of the initiation and progression of melanoma (1)
Chairs: R. Luiten - N. Hayward - R. Ballotti
08:30 to 09:00 Hall A GL5
Y. Hayashizaki :
Availability of transcriptional regulatory network analysis by next-generation sequencer09:00 to 09:20 Hall A IL30
D. Fisher:
"Whole-genome sequencing identifies a novel melanoma susceptibility variant in MITF"09:20 to 09:42 Hall A C68
A.K. Indra:
"Novel role of melanocytic RXR alpha /RXR beta in UV irradiation induced melanocyte homeostasis"09:42 to 09:54 Hall A C69
F.P. Noonan:
"Two UV pathways to melanoma"09:54 to 10:06 Hall A C70
M.H. Ogmundsdottir:
"The Mitf structure unravels DNA binding and dimerization specificities"10:06 to 10:18 Hall A C71
R. Balloti:
"Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells"10:18 to 10:30 Hall A Discussion
to Coffee Break 11:00 to 12:30 Hall A Fundamental aspects of the initiation and progression of melanoma (2)
Chairs: L. Montoliu - Z. Ronai, A. Spatz
11:00 to 11:20 Hall A IL31
M. Davies:
"Regulation and Function of the PI3K Pathway in Advanced Melanoma"11:20 to 11:40 Hall A IL32
B. Bastian:
"Oncogenic signaling downstream of Gq/11"11:40 to 12:00 Hall A IL33
R. Marais:
"RAS and RAF signalling in melanoma: translating biology into therapies"
12:00 to 12:12 Hall A C72
N. Dumaz:
"When CRAF takes over from BRAF in melanoma using ERK and PDE4"12:12 to 12:24 Hall A C73
C. Wellbrock:
"A novel link between TGFbeta and MAP kinase signalling is involved in resistance to MEK inhibition in melanoma"to Lunch Break and Poster Discussion to Halls A, B, C Concurrent sessions 16-18
14:30 Hall A CS16: Preclinical and clinical advances in melanoma management (SMR-IFPCS)
Chairs: B. Bastian - L. Larue - B. Guillot
14:00 to 14:20 Hall A IL34
C. Garbe:
"New developments in melanoma therapy - ASCO update"14:20 to 14:32 Hall A C74
A.K. Ganesan:
"Synthetic Lethal RNAi-screening Uncovers a Novel Role for Rho Family GTPases in Controlling Cell Fate and Chemoresistance"14:32 to 14:44 Hall A C75
R.W. Dellinger:
"Functional Role for the UDP-Glucuronosyltransferases (UGTs) in Melanoma Drug Resistance"14:44 to 14:56 Hall A C76
K. Jimbow:
"Introduction of melanoma in situ peptide vaccine by chemothermotherapy through exploitation of melanogenesis substrate, NPrCAP, and its conjugation with magnetite nanoparticles"14:56 to 15:08 Hall A C77
F. Journe:
"cKIT expression level and NRAS/BRAF mutation status predict the response to the tyrosine kinase inhibitor dasatinib in melanoma cell lines"15:08 to 15:20 Hall A C78
D. Lang:
"Promotion of melanoma growth and survival through Glycogen Synthase Kinase-3 protein activity"15:20 to 15:30 Hall A Discussion
Hall C CS17: New pathomechanisms in melanoma: redox status, autophagy…
Chairs: F. Meyskens - María.S. Soengas - N. Basset-Seguin
14:00 to 14:20 Hall C IL35
F.L. Meyskens:
"Chemoprevention of melanoma progression mediated by NO/neural NO synthase (nNOS), an accelerator of the transformation process"14:20 to 14:40 Hall C IL36
M. Soengas:
"Endolysosomal pathways in melanoma maintenance and drug response"14:40 to 15:00 Hall C IL37
D.C. Bennett:
"Impacts of p16 deficiency on melanocyte gene expression and biology: relation to early melanoma"15:00 to 15:12 Hall C C79
J.C. Valencia:
"Fighting Proliferation with Differentiation: How Pmel17/gp100 binding to FHL2 leads the charge in melanoma"15:12 to 15:24 Hall C C80
C. Bertolotto:
"Senescent cells develop a secretome "Hall B CS18: Immune depigmentation in melanoma and vitiligo clinically-oriented
Chairs: D. Norris - W. Westerhof - C. Lebbé
14:00 to 14:20 Hall B IL38
R.M. Luiten:
"Monobenzome increases the immunogenicity of melanoma cells, and is effective as melanoma immunotherapy"14:20 to 14:32 Hall B C81
M.W. Kroon :
"Effect of UVB therapy on the lymphocytic infiltrate in the skin of vitiligo patients"14:32 to 14:44 Hall B C82
J. Klarquist:
"Functional cloning of a gp100-reactive TCR from depigmenting vitiligo skin"14:44 to 14:56 Hall B C83
S. Yang:
"APE/Ref-1, a druggable target for the therapy of human melanoma"14:56 to 15:08 Hall B C84
M.-J. Pierrat:
"Involvement of TGF-beta signaling and the GLI2 transcription factor in M-MITF regulation and pigmentation in melanoma cells"15:08 to 15:20 Hall B C85
N. Chin:
"Edn3 promotes metastasis and alters tumor heterogeneity in a mouse model of melanoma"16:10 to 16:22 Hall A C86
M. Hossain.:
"Markers of telomeric crisis and immortalization in melanoma progression"to Halls A, B, C Concurrent sessions 19-21
15:30 Hall A CS19: Clinical advances in melanoma management (SMR-IPCC)
Chairs: P. Chapman - G. Ghanem - P. Saiag
15:30 to 15:50 Hall A IL39
R.D. Carvajal:
"KIT Aberrations in Melanoma and Therapeutic Implications "15:50 to 16:10 Hall A IL40
G. Ghanem:
"TYRP1, a missing link between melanogenesis and melanoma progression ?"16:22 to 16:34 Hall A C87
D. S. Widmer:
"The role of hypoxia in melanoma phenotype switching"16:34 to 16:46 Hall A C88
M. Tichet:
"SPARC acts as a VCAM-1 ligand to mediate melanoma extravasation and distant metastasis"16:46 to 16:58 Hall A C89
A.P. Benaduce:
"Melanocytes and melanoma cells present different mechanical properties that can be modulated by Endothelin 3"Hall B CS20: Congenital nevus clinically-oriented
Chairs: H. Etchevers - V. Kinsler - B. Vergier
15:30 to 15:50 Hall B IL41
V. Kinsler:
"Congenital Melanocytic Nevus Syndrome: clinical and genetic aspects"15:50 to 16:10 Hall B IL42
H. Etchevers:
"Genomics and the molecular etiologies of congenital nevus formation"16:10 to 16:22 Hall B C90
V. Delmas:
"Understanding Melanocyte Development: Biological analysis associated with mathematical modeling"16:22 to 16:34 Hall B C91
M. Reyes-Múgica:
"Cellular Dynamics In Congenital Melanocytic Nevi: Is “Maturation With Depth” A One-Way Road?"16:34 to 16:46 Hall B C92
A. Rebbaa:
"Epithelial to mesenchymal - like transition is an earlier cellular response to stress than senescence: potential role as a target for cancer prevention"16:46 to 16:58 Hall B C93
O. Eichhoff:
"Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching"Hall C CS21: Xeroderma pigmentosum clinically-oriented
Chairs: A. SARASIN - H. de Verneuil
15:30 to 15:50 Hall C IL43
A. Sarasin:
"The xeroderma pigmentosum syndrome: clinical, genetic and gene therapy issues"15:50 to 16:10 Hall C IL44
H.R. Rezvani:
"Xeroderma pigmentosum: clues to understand cancer initiation"16:10 to 16:22 Hall C C94
H.H. Hu:
"A large French case-control study assessing the association of MC1R with melanoma: the unexpected role of non-RHC and rare MC1R variants"16:22 to 16:34 Hall C C95
S. Corre:
"USF1 is critical for the regulation of ner genes essential for early recognition of UV induced DNA-Photolesions"16:34 to 16:46 Hall C C96
S. Meierjohann:
"Evasion of ROS-dependent pigment cell senescence"16:46 to 16:58 Hall C C97
V. Swope:
"Induction of γ-H2AX by UV and α-melanocyte stimulating hormone, and implications on DNA repair in human melanocytes"to Hall A iFPCS General Assembly
to at Château
GiscoursGala Dinner at Château Giscours
departure of the buses at 19:00 from the Conference Center
- Myron Gordon Award (IFPCS),
- Takeuchi medal (JSPCR),
- Raper medal (ESPCR),
- Thomas B. Fitzpatrick Award,
- Poster Prizes -
Saturday 24th, September 2011
to Hall A Plenary session VII
Hall A Translational research (1)
Chairs: G. Barsh - Y. Tomita - MF. Avril
08:30 to 09:00 Hall A GL6
J.M. EGLY :
Xeroderma pigmentosum and trichothiodystrophy: understanding cancer and non cancer phenotypes09:00 to 09:20 Hall A IL45
D.J. Tobin:
"The human hair-bulb melanocyte: a model aging system for both our gray hair and our gray matter?"09:20 to 09:32 Hall A C98
H.E. Teulings:
"Retrospective analysis of melanoma and non-melanoma skin cancer incidence in a large vitiligo patient cohort"09:32 to 09:44 Hall A C99
J.E. Harris:
"A new mouse model of vitiligo with epidermal depigmentation reveals a critical role for IFN-gamma in autoreactive T cell homing to the skin"09:44 to 09:56 Hall A C100
J. Klarquist:
"Spontaneous epidermal depigmentation in mice - a model for vitiligo"09:56 to 10:08 Hall A C101
S. Itoi:
"Descriptive Assessment on Dynamic Change of Dendritic Cell Distribution Both in Epidermis and Dermis of the Lesional Skin in Generalized Vitiligo Vulgaris: Link between Cellular Autoimmune Response and Melanocyte Disappearance"10:08 to 10:20 Hall A C102
A. Tanemura:
"Dysregulation of Melanocyte Function and Survival Induced by Th17-Related Cytokines and Their Involvement in the Pathogenesis for Vitiligo Vulgaris"10:20 to 10:30 Hall A Discussion
to Coffee Break to Hall A Plenary session VIII
Hall A Translational research (2)
Chairs: H. Arnheiter - D. Gawkrodger - F. Tison
11:00 Hall A GL7
T. Luger :
Alpha MSH: a major component of the skin immune system with a therapeutic potential11:30 Hall A GL8
L. Zecca :
Neuromelanins in brain aging and Parkinson's disease12:00 to 12:12 Hall A C103
C. Grill:
"The role of Interferon Regulatory Factor 4 (IRF4) in pigmentation"12:12 to 12:24 Hall A C104
R. L. Mort:
"Live imaging and mathematical modeling of the role of Kit/Kitl in melanoblast behaviour"12:24 to 12:36 Hall A C105
T. Cheng:
"Melanocyte adaptation to ER stress and activation of the unfolded protein response in Oca2-null melanocytes"12:36 to 12:48 Hall A C106
J.M. Pawelek:
"LC3B punctate expression, a marker for autophagosomes, is a common feature of melanomas and breast carcinomas and associated with proliferation, metastasis, high nuclear grade and poor outcome"12:48 to 13:00 Hall A Discussion
to Lunch break / Industry Symposiums to A, B, C Concurrent sessions 22-24
Hall A CS22: Vitiligo:
Report on Global Issues Consensus Conference and selected papers clinically-orientedChairs: I. Katayama - H. Lim - C. Silvia de Castro
14:30 to 14:50 Hall A IL46
A. Taïeb on behalf of VGICC panelists:
"VGICC: Objectives and priorities for international consensus"14:50 to 15:10 Hall A IL47
D.-Y. Lee :
"Treatment guideline in segmental vitiligo"15:10 to 15:22 Hall A C107
B. Bellei:
"Alterations of cellular redox-sensitive pathways regulation in vitiligo melanocytes converge to stress-activated cellular senescence phenotype"15:22 to 15:34 Hall A C108
V. Eleftheriadou:
"Systematic review of outcome measurements for the treatment of vitiligo"15:34 to 15:46 Hall A C109
T. Anbar:
"The paradox of the effects of PGF2alpha on pigmentation in vivo and in vitro"15:46 to 15:58 Hall A C110
A. Ramaiah:
"Double blind randomized clinical trial on bFGF related deca peptide to treat vitiligo "Hall C CS23: Albinism: Basic science and patient-oriented session clinically-oriented
Chairs: T. Suzuki - R. Aquaron - B. Arveiler
14:30 to 14:50 Hall C IL48
B. Arveiler:
"The genetics of oculocutaneous albinism"14:50 to 15:10 Hall C IL49
T. Suzuki:
"What's new in albinism among Japanese 2011"15:10 to 15:22 Hall C C111
W. Li:
"An optimized strategy for genetic testing of the Chinese patients with oculocutaneous albinism"15:22 to 15:34 Hall C C112
E. Moltó:
"Albinochip: a universal genetic diagnosis for all known mutations associated to albinism"15:34 to 15:46 Hall C C113
R. Aquaron:
"Oculocutaneous albinism type I (OCAI) in the Jewish populations of mediterranean sea countries (Algeria, Morocco, Tunisia): A story of the p.Gly47Asp mutation on the tyrosinase gene and personal data about 5 cases"15:46 to 15:58 Hall C C114
A.R. Cullinane:
"BLOC-1 mutation screening in Hermansky-Pudlak Syndrome reveals a new HPS subtype, HPS-9, associated with mutations in PLDN(pallidin) and a novel BLOS3 (HPS-8) mutation."Hall B CS24: Skin depigmenting agents, from basic mechanisms to application:
focus on melasma clinically-orientedChairs: K. Al Ghamdi - N. Al Mutairi - M.H. Lee
14:30 to 14:50 Hall B IL50
H.Y. Kang:
"Overview: Skin lightening agents and melasma"14:50 to 15:02 Hall B C115
W. Choi:
"Characterization of the bioactive motif of neuregulin-1, a fibroblast-derived paracrine factor that regulates constitutive color and melanocyte function in human skin"15:02 to 15:14 Hall B C116
Y. Huang:
"Active vitiligo lesions are more responsive to combination therapy with narrowband ultraviolet light B and topical tacrolimus"15:14 to 15:26 Hall B C117
K.M. Al Ghamdi:
"Depigmentation therapies for normal skin in vitiligo universalis"15:26 to 15:38 Hall B C118
M. Tanaka:
"Topical rapamycin therapy is effective for hypomelanotic macules arising in tuberous sclerosis complex"15:38 to 16:00 Hall A Discussion
to Coffee Break to Hall A Close of ipcc2011
Chairs: K. Jimbow - J.P. Ortonne - J. Valencia
16:30 to 17:00 Hall A SL5: Fitzpatrick Lecture
T. Kunisada : "Functionally distinct melanocyte populations revealed in mice: noncutaneous and dermal melanocytes versus epidermal melanocytes"
Closing remarks and announcements